Does Fatty Liver Cause Diarrhea? Understanding the Gut-Liver Connection
Fatty liver affects your digestive system in ways you least expect. It has been shown that digestive problems, specifically bowel changes, are more common effects of fatty liver than many people realize if the liver has been compromised. So, does fatty liver cause diarrhea? There are things you should explore.
Understanding how your liver and gut work together can help explain why there are people who experience ongoing digestive issues alongside fatty liver disease. This connection between liver health and bowel function involves a complex biological process that is not fully understood yet.
Key Insights
-
Up to 25% of patients with MASLD experience chronic diarrhea due to a disrupted gut-liver communication
-
Bile acid malabsorption is the primary mechanism causing digestive symptoms in patients with fatty liver
-
Stool changes include pale, fatty, or oily appearance often accompany diarrhea in liver disease
-
Early intervention with lifestyle changes can improve both liver health and digestive symptoms
-
Persistent digestive issues warrant medical evaluation to rule out disease progression
Can Fatty Liver Disease Lead to Diarrhea?
Yes, research shows that about 25% of people with MASLD (metabolic dysfunction-associated steatotic liver disease, formerly called NAFLD) experience chronic diarrhea. This percentage represents a significant portion of patients who develop ongoing digestive issues alongside their existing liver condition.
The connection between fatty liver and digestive problems comes from the liver’s crucial role in digestion. Your liver produces bile acids that help break down fats and regulate bowel movements. When fatty deposits accumulate in the liver, this process becomes disrupted.
Multiple researches have demonstrated a clear relationship between MASLD and gastrointestinal symptoms. These researches reveal that people who suffer from fatty liver disease are more likely to experience:
-
Chronic loose stools that could last for more than four weeks
-
Changes in bowel movement frequency
-
Digestive discomfort especially after eating fatty foods
-
Irregular stool consistency patterns
What's the Evidence and How Common Is It?
Clinical studies have provided concrete evidence about the prevalence of digestive issues in fatty liver patients. In a study, it was found that diarrhea is present in about 6.6% of patients enrolled in a study. Another study had diarrhea occurring in about 13.3% of patients.
Liver cirrhosis, which represents the most advanced form of liver disease, demonstrates the highest rates of digestive symptoms. About 80% of cirrhotic patients have one or more related digestive symptoms. The most prevalent specific digestive symptoms include the following:
-
Abdominal bloating
-
Abdominal pain
-
Belching
-
Diarrhea
-
Constipation
Additionally, digestive symptoms like diarrhea may also be disease-specific. Studies done on hospitalized patients stated that about 18% of them reported digestive symptoms, with diarrhea occurring as the most common symptoms at 11.8%. The prevalence of these digestive symptoms increases significantly in patients with more severe disease.
For patients with MASLD, research revealed that patients experience functional dyspepsia at about 25%. Specific digestive symptoms in these patients include:
-
Postprandial distress
-
Epigastric pain or burning
-
Postprandial fullness
Digestive symptoms are often present in acute viral hepatitis although the prevalence varies depending on the virus type and patient age. For example, in hepatitis A, about 70% of adults develop symptomatic disease typically involving gastrointestinal symptoms like nausea, vomiting, poor appetite, and abdominal discomfort. Most of these symptoms persist in about 2-8 weeks, particularly during the acute phase.
It is also important to note that there is a relationship between the severity of liver disease and digestive symptom prevalence. It is measured by Child-Pugh scores and MELD scores.
The relationship between liver disease severity and digestive symptom prevalence is well-established. Gastrointestinal symptom severity correlates directly with liver disease severity, as measured by Child-Pugh scores and MELD scores. Patients with decompensated cirrhosis experience more frequent and severe digestive symptoms compared to those with compensated disease. Specific symptoms often emerge, like:
-
Anorexia
-
Weight loss
-
Early satiety
Medical research continues to track these patterns to better understand why some patients develop digestive symptoms. Nonetheless, not all patients with liver disease experience digestive symptoms.
How Does the Gut-Liver Axis Contribute?
The gut-liver axis is a two-way communication network between the intestine, its microbiota, and the liver. It is very important for the development and worsening of digestive symptoms in liver disease. This complicated system works through many linked pathways that cause a loop of intestinal malfunction and liver damage that keeps going on its own.
Basic foundation
There are direct connections between the stomach and the liver that make it possible for them to talk to each other all the time. The portal vein system sends things from the stomach, like nutrients, bacterial waste products, and perhaps dangerous compounds, straight to the liver. At the same time, the liver sends messages back to the intestine by bile acid secretion through the biliary canal. This helps keep the gut microbiota in check and working properly.
Because of this anatomical configuration, 75% of the liver's blood supply comes directly from the intestines. This implies that the liver is always exposed to compounds from the gut, making it a "second firewall" against potentially dangerous intestinal contents.
When fatty deposits accumulate within the liver tissue, several disruptions occur within this communication system:
-
Bile acid processing changes
-
Bacterial balance changes
-
Immune system activation
-
Nutrient absorption problems
These are all interconnected changes that create a cycle where liver problems will result in worsening gut health. This will then send an inflammatory signal back to the liver, which could worsen the fatty deposits.
Why Does Fatty Liver Disrupt Digestion?
Fatty liver impairs bile handling and gut balance through multiple mechanisms. Your liver’s ability to produce, store, and release bile becomes compromised particularly when fat has accumulated with its cells. The digestive disruption occurs because the bile acids produced by the liver serve multiple functions more than fat digestion. These molecules regulate gut bacteria, control inflammation, and influence bowel movement timing, and consistency.
How Do Bile Acids and Malabsorption Cause Diarrhea?
Bile acid malabsorption occurs when your liver produces chemically altered bile acids. These chemically changed bile acids are not properly reabsorbed by the intestines. Bile acids are like soaps or detergents. When they’re made with the wrong chemicals, they don’t clean up properly once their function is done.
Normally, approximately 95% of bile acids get reabsorbed back to the liver once they’ve helped digest fats. With fatty liver disease, the recycling process becomes inefficient. The excess bile acids that are not reabsorbed flow into the large intestine (colon) where they:
-
Irritate the colon lining, which triggers immune responses
-
Draw extra water into the bowel, creating loose stools
-
Speed up intestinal transit time, which reduces water reabsorption
-
Disrupt the normal bacteria balance in your colon
The protein FGF19 normally sends signals to the liver so it stops producing bile acids when adequate amounts are present. However, in fatty liver disease, this feedback system malfunctions, which leads to bile acid overproduction and subsequently causes digestive problems.
What Role Do IBS-D and SIBO Play?
Irritable bowel syndrome with diarrhea (IBS-D) occurs more frequently in individuals with fatty liver disease. It has been shown that nearly 40% of MASLD patients also meet the criteria for IBS-D, which is higher than the lower rates in the general population.
Small intestinal bacterial overgrowth (SIBO) develops when the disrupted flow of bile allows the bacteria to multiply in areas where they don’t typically thrive. The chemical alteration in the bile acids of fatty liver patients often creates the ideal condition for bacterial overgrowth.
These conditions often occur together, creating overlapping symptoms, such as:
-
Abdominal bloating
-
Gas production
-
Unpredictable bowel movement timing
-
Cramping pain before bowel movements
-
Relief of symptoms after passing stools
The combination of these two conditions (IBS-D and SIBO) with fatty liver creates a complex digestive image that requires comprehensive management approaches that should be able to address all three conditions simultaneously.
What Other Bowel Symptoms Occur with Fatty Liver?
Apart from diarrhea, you may see fatty, pale, or even tarry stools as signs of liver-related digestive problems. These changes in stool appearance offer important clues about how well your liver is still functioning. Stool color and consistency changes often develop progressively over time, which makes it difficult to identify initially. However, these subtle changes can signal significant disruptions in liver function and bile production.
Why Can Fatty or Pale Stools Appear?
An impairment in bile production leads to characteristic stool changes that reflect poor fat digestion. When your liver cannot produce sufficient amounts of functioning bile, dietary fats pass through your digestive system without being processed properly and effectively.
Characteristics of stools include:
-
Pale or clay-colored stools: Normal stools are often colored brown due to the natural bile pigments. When bile production decreases, the stools become lighter in color. It can sometimes appear gray or clay-like as well.
-
Fatty or greasy appearing stools: Undigested and improperly processed fats produce stools that:
-
Float on water surface because of the high fat content
-
Appear shiny or greasy when examined
-
Stick to toilet bowls and resist flushing
-
Produce particularly unpleasant odors
-
Oil residue: Some people report residual oily droplets or films of oil on the water after bowel movements, which could indicate significant fat malabsorption
These stool changes often come along with other digestive symptoms like bloating after a fatty meal, decreased appetite, and feelings of incomplete digestion.
When Is Diarrhea a Sign of Progression to Cirrhosis?
Diarrhea becomes a concerning sign when it appears alongside other symptoms that suggest liver disease progression. Advanced NASH (non-alcoholic steatohepatitis) and early cirrhosis often present with more severe digestive symptoms.
Warning signs that diarrhea may indicate serious liver progression include:
-
Jaundice (yellow discoloration of skin and eyes)
-
Dark urine
-
Abdominal swelling that worsens over time
-
Severe fatigue that isn’t relieved with rest
-
Easy bruising or even bleeding
When diarrhea occurs with these symptoms, immediate and proper medical evaluation are essential. The digestive symptoms in advanced liver disease often worsen rapidly and would require specialized treatment approaches.
When Should You Talk to a Doctor About Diarrhea and Fatty Liver?
Seek help if diarrhea is persistent or accompanied by liver-related symptoms like yellow skin or eyes, dark urine, and abdominal swelling–to name a few. These combinations of symptoms suggest that your liver function may be declining and requires professional medical assessment.
Many people delay seeking medical attention for digestive symptoms, thinking they’ll resolve on their own. However, when faced with fatty liver disease, persistent digestive changes often indicate that there is a need for treatment adjustments or may even need additional interventions.
What Red-Flag Signs Should Prompt Medical Help?
Certain symptom combinations require immediate medical evaluation because they may indicate serious liver complications:
-
Persistent jaundice
-
Dark cola-colored urine
-
Severe abdominal swelling
-
Unintentional or unexplained weight loss
-
Extreme fatigue
-
Easy bleeding
-
Mental confusion or disorientation
Additional concerning patterns include diarrhea that worsens despite dietary changes, blood in stools, or severe cramping that interferes with sleep or work activities.
Which Tests or Treatments May Be Recommended?
Diagnostic evaluation for fatty liver-related digestive symptoms typically includes several assessment approaches:
-
Blood tests
-
Imaging studies
-
Stool analysis
-
Breath tests
Blood tests often include liver function tests, inflammatory markers panel, and nutritional assessments. Imaging studies include ultrasound, computed tomography (CT) scan, and magnetic resonance imaging (MRI) for visualization of the liver. A specialized elastography like FibroScan may also be employed to determine liver stiffness and fat content to assess the extent of disease. Laboratory examination of the stool, on the other hand, identifies cases of fat malabsorption, bacterial overgrowth, and inflammatory markers. Specialized tests like breath tests determine presence of SIBO or measure bile acid malabsorption rates.
If you’re the type to be proactive about your health, you may also opt for at-home strips, which may determine the status of your urine. This may also help determine if glucose is detectable in the urine that serves as an overview of how well your liver is processing nutrients like carbohydrates.
Treatment approaches often combine lifestyle interventions with targeted medications:
-
Dietary adjustments (low fat, restrictions on specific carbohydrates, or supervised weight loss programs)
-
Bile acid binders
-
Probiotics
-
FXR agonists (medications that help regulate bile acid)
Quick Summary Box
-
Fatty liver disease creates digestive problems through disrupted bile acid production and gut-liver communication
-
Up to 25% of patients experience chronic diarrhea, while many more notice stool changes including pale, fatty, or oily appearance
-
The primary mechanism involves bile acid malabsorption, which irritates the colon and disrupts normal bacterial balance
-
Early recognition and treatment of both liver and digestive symptoms can prevent progression to more serious complications
-
Persistent digestive changes in people with fatty liver warrant medical evaluation to assess disease progression and optimize treatment approaches
Related Resources
Does Semaglutide Cause Liver Damage? Key Things to Know
What Part of the Body Itches with Liver Damage? Evidence-Based Guide
References
Albillos, A., Gottardi, A. de, & Rescigno, M. (2020). The gut-liver axis in liver disease: Pathophysiological basis for therapy. Journal of Hepatology, 72(3), 558–577. https://doi.org/10.1016/j.jhep.2019.10.003
Appleby, R. N., Moghul, I., Khan, S., Yee, M., Manousou, P., Neal, T. D., & Walters, J. R. F. (2019). Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study. PLOS ONE, 14(1), e0211348. https://doi.org/10.1371/journal.pone.0211348
Choudhuri, S., & Klaassen, C. D. (2021). MOLECULAR REGULATION OF BILE ACID HOMEOSTASIS. Drug Metabolism and Disposition, DMD-MR-2021-000643. https://doi.org/10.1124/dmd.121.000643
Kalaitzakis, E. (2014). Gastrointestinal dysfunction in liver cirrhosis. World Journal of Gastroenterology, 20(40), 14686. https://doi.org/10.3748/wjg.v20.i40.14686
Kalaitzakis, E., Simrén, M., Olsson, R., Henfridsson, P., Hugosson, I., Bengtsson, M., & Björnsson, E. (2006). Gastrointestinal symptoms in patients with liver cirrhosis: Associations with nutritional status and health-related quality of life. Scandinavian Journal of Gastroenterology, 41(12), 1464–1472. https://doi.org/10.1080/00365520600825117
Lima, É. C., Passos, M. do C. F., Ferolla, S. M., Costa, R. S. N. da, Lisboa, Q. C., Pereira, L. I. D., Nardelli, M. J., Arantes, V. N., Ferrari, T. C. de A., & Couto, C. A. (2022). High prevalence of functional dyspepsia in nonalcoholic fatty liver disease: a cross-sectional study. Sao Paulo Medical Journal, 140(2), 199–206. https://doi.org/10.1590/1516-3180.2021.0015.r1.14062021
Nicoletti, A., Ponziani, F. R., Biolato, M., Valenza, V., Marrone, G., Sganga, G., Gasbarrini, A., Miele, L., & Grieco, A. (2019). Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World Journal of Gastroenterology, 25(33), 4814–4834. https://doi.org/10.3748/wjg.v25.i33.4814
Shin, A., Xu, H., & Imperiale, T. F. (2019). Associations of chronic diarrhoea with non-alcoholic fatty liver disease and obesity-related disorders among US adults. BMJ Open Gastroenterology, 6(1), e000322. https://doi.org/10.1136/bmjgast-2019-000322
Tcaciuc, E., Olaru-Stavila, C., Alexa, Z., Tcaciuc, A., & Ardeleanu, D. (2022). Gastrointestinal manifestations in hospitalized patients with chronic liver disease and COVID-19. Medicine and Pharmacy Reports, 94(3), S6–S11. https://doi.org/10.15386/mpr-2516
Wu, X., Ge, H., Baribault, H., Gupte, J., Weiszmann, J., Lemon, B., Gardner, J., Fordstrom, P., Tang, J., Zhou, M., Wang, M., & Li, Y. (2013). Dual actions of fibroblast growth factor 19 on lipid metabolism. Journal of Lipid Research, 54(2), 325–332. https://doi.org/10.1194/jlr.m027094
Yu, J.-X., Wu, J., Chen, X., Zang, S.-G., Li, X.-B., Wu, L.-P., & Xuan, S.-H. (2025). Gut microbiota in liver diseases: initiation, development and therapy. Frontiers in Medicine, 12. https://doi.org/10.3389/fmed.2025.1615839
Zhou, Y., Yang, Z., Liu, S., Xie, S., Zhang, Q., Zhang, S., Zhu, S., & Wu, S. (2025). Long-term risk of irritable bowel syndrome associated with MASLD, MASLD type and different cardiometabolic risk factors: a large-scale prospective cohort study. BMC Gastroenterology, 25, 576. https://doi.org/10.1186/s12876-025-04165-7
